Search research articles
Contact Us
Filters
Showing results (1-10 of 3) with videos related to
Page
of 1
Sort By:
Cancer Letters
|
March 16, 2019
P53 pathway is a major determinant in the radiosensitizing effect of Palbociclib: Implication in cancer therapy
D M Fernández-Aroca, O Roche, S Sabater, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
December 14, 2020
p38β (MAPK11) mediates gemcitabine-associated radiosensitivity in sarcoma experimental models
R Pascual-Serra, D M Fernández-Aroca, S Sabater, et al.
Clinical and Translational Radiation Oncology
|
June 22, 2023
MAPK11 (p38β) is a major determinant of cellular radiosensitivity by controlling ionizing radiation-associated senescence: An in vitro study
D M Fernández-Aroca, N García-Flores, S Frost, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 3) with videos related to
Sort By:
Page
of 1
Cancer Letters
|
March 16, 2019
P53 pathway is a major determinant in the radiosensitizing effect of Palbociclib: Implication in cancer therapy
D M Fernández-Aroca, O Roche, S Sabater, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
December 14, 2020
p38β (MAPK11) mediates gemcitabine-associated radiosensitivity in sarcoma experimental models
R Pascual-Serra, D M Fernández-Aroca, S Sabater, et al.
Clinical and Translational Radiation Oncology
|
June 22, 2023
MAPK11 (p38β) is a major determinant of cellular radiosensitivity by controlling ionizing radiation-associated senescence: An in vitro study
D M Fernández-Aroca, N García-Flores, S Frost, et al.
Page
of 1